Most Popular

M & A Deals | M & A League Table | Real Assets | Sector Events |  Private Capital Conference

From uncertainty to opportunity: life sciences dealmaking resets – Insights from McDermott Will & Schulte’s Life Sciences Symposium

Analysis Nick Herbert -
Against a backdrop of geopolitical tension, valuation resets and shifting capital markets, life sciences dealmaking is not slowing, it is recalibrating. The tone at McDermott Will & Schulte’s Life Sciences Symposium, held in Paris in March, reflected that shift. The message from across panels was consistent: uncertainty has not stalled...

Lithuania: Sectra strengthens position as provider of advanced, regulatory-approved AI solutions for diagnostic imaging with acquisition of Oxipit

Diagnostics Nick Herbert -
Sweden-based international medical imaging IT and cybersecurity company Sectra has completed the acquisition of Lithuania-based Oxipit, a pioneer in autonomous AI for radiology and the developer of the first solution with CE Class IIB certification for autonomous chest X-ray analysis. The deal strengthens Sectra’s position as a provider of advanced, regulatory-approved AI solutions for diagnostic imaging. Since 2017, Oxipit has been building radiology tools that analyse chest X-rays, support faster diagnoses, and ease the workload for clinical teams. Oxipit's CXR Suite is a certified, powerful portfolio of radiology AI tools designed...